Tag: generic drug patents
Paragraph IV Patent Challenges: How Generic Drug Makers Beat Brand Patents
Paragraph IV patent challenges let generic drug makers legally fight brand patents before they expire. This Hatch-Waxman Act tool speeds up affordable drug access and has saved U.S. consumers over $1.2 trillion since 1990.
read more